(Q71603077)
Statements
Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study (English)
Egsmose C
Lund B
Borg G
Pettersson H
Berg E
Brodin U
1 December 1995